Novel éthynylxanthines, their preparation and use as inhibitors of matrix metalloproteinases and angiogenesis

The present invention relates to a novel ethynylxanthine derivatives of formula (I) which exhibit ability selectively suppress matrix metalloproteinases and therefore may act as inhibitors of angiogenesis, methods for their synthesis and use for the treatment and/or prevention of various diseases an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Valerjans Kauss, Ilona Domracheva, Irina Shestakova, Anita Gulbe, Jelena Vasiljeva, Pavels Arsenjans, Ivars Kalvins, Iveta Kanepe-Lapsa
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Valerjans Kauss
Ilona Domracheva
Irina Shestakova
Anita Gulbe
Jelena Vasiljeva
Pavels Arsenjans
Ivars Kalvins
Iveta Kanepe-Lapsa
description The present invention relates to a novel ethynylxanthine derivatives of formula (I) which exhibit ability selectively suppress matrix metalloproteinases and therefore may act as inhibitors of angiogenesis, methods for their synthesis and use for the treatment and/or prevention of various diseases and disorders caused by overexpression of matrix metalloproteinases by administration of such substances
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_GB2553685A8</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>GB2553685A8</sourcerecordid><originalsourceid>FETCH-epo_espacenet_GB2553685A83</originalsourceid><addsrcrecordid>eNqNjLsNwlAMANNQIGAHDwANUVBaQHwqKvrIgEMsvdhPzwYlIzEHixEhBqC65u7GmZz0SQHeL2966UOH4g0L2Ry8IU4QE0VM6KwCKDd4GAEasDR8YddkoDW06Ik7aMkxBI1JnVjQyL4Jyp31TsOUbZqNagxGsx8nGex35-1xQVErsojXwfPqsFkWRb4qi3WZ_6F8AFxhRBE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Novel éthynylxanthines, their preparation and use as inhibitors of matrix metalloproteinases and angiogenesis</title><source>esp@cenet</source><creator>Valerjans Kauss ; Ilona Domracheva ; Irina Shestakova ; Anita Gulbe ; Jelena Vasiljeva ; Pavels Arsenjans ; Ivars Kalvins ; Iveta Kanepe-Lapsa</creator><creatorcontrib>Valerjans Kauss ; Ilona Domracheva ; Irina Shestakova ; Anita Gulbe ; Jelena Vasiljeva ; Pavels Arsenjans ; Ivars Kalvins ; Iveta Kanepe-Lapsa</creatorcontrib><description>The present invention relates to a novel ethynylxanthine derivatives of formula (I) which exhibit ability selectively suppress matrix metalloproteinases and therefore may act as inhibitors of angiogenesis, methods for their synthesis and use for the treatment and/or prevention of various diseases and disorders caused by overexpression of matrix metalloproteinases by administration of such substances</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2018</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20180418&amp;DB=EPODOC&amp;CC=GB&amp;NR=2553685A8$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20180418&amp;DB=EPODOC&amp;CC=GB&amp;NR=2553685A8$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Valerjans Kauss</creatorcontrib><creatorcontrib>Ilona Domracheva</creatorcontrib><creatorcontrib>Irina Shestakova</creatorcontrib><creatorcontrib>Anita Gulbe</creatorcontrib><creatorcontrib>Jelena Vasiljeva</creatorcontrib><creatorcontrib>Pavels Arsenjans</creatorcontrib><creatorcontrib>Ivars Kalvins</creatorcontrib><creatorcontrib>Iveta Kanepe-Lapsa</creatorcontrib><title>Novel éthynylxanthines, their preparation and use as inhibitors of matrix metalloproteinases and angiogenesis</title><description>The present invention relates to a novel ethynylxanthine derivatives of formula (I) which exhibit ability selectively suppress matrix metalloproteinases and therefore may act as inhibitors of angiogenesis, methods for their synthesis and use for the treatment and/or prevention of various diseases and disorders caused by overexpression of matrix metalloproteinases by administration of such substances</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2018</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjLsNwlAMANNQIGAHDwANUVBaQHwqKvrIgEMsvdhPzwYlIzEHixEhBqC65u7GmZz0SQHeL2966UOH4g0L2Ry8IU4QE0VM6KwCKDd4GAEasDR8YddkoDW06Ik7aMkxBI1JnVjQyL4Jyp31TsOUbZqNagxGsx8nGex35-1xQVErsojXwfPqsFkWRb4qi3WZ_6F8AFxhRBE</recordid><startdate>20180418</startdate><enddate>20180418</enddate><creator>Valerjans Kauss</creator><creator>Ilona Domracheva</creator><creator>Irina Shestakova</creator><creator>Anita Gulbe</creator><creator>Jelena Vasiljeva</creator><creator>Pavels Arsenjans</creator><creator>Ivars Kalvins</creator><creator>Iveta Kanepe-Lapsa</creator><scope>EVB</scope></search><sort><creationdate>20180418</creationdate><title>Novel éthynylxanthines, their preparation and use as inhibitors of matrix metalloproteinases and angiogenesis</title><author>Valerjans Kauss ; Ilona Domracheva ; Irina Shestakova ; Anita Gulbe ; Jelena Vasiljeva ; Pavels Arsenjans ; Ivars Kalvins ; Iveta Kanepe-Lapsa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_GB2553685A83</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2018</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Valerjans Kauss</creatorcontrib><creatorcontrib>Ilona Domracheva</creatorcontrib><creatorcontrib>Irina Shestakova</creatorcontrib><creatorcontrib>Anita Gulbe</creatorcontrib><creatorcontrib>Jelena Vasiljeva</creatorcontrib><creatorcontrib>Pavels Arsenjans</creatorcontrib><creatorcontrib>Ivars Kalvins</creatorcontrib><creatorcontrib>Iveta Kanepe-Lapsa</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Valerjans Kauss</au><au>Ilona Domracheva</au><au>Irina Shestakova</au><au>Anita Gulbe</au><au>Jelena Vasiljeva</au><au>Pavels Arsenjans</au><au>Ivars Kalvins</au><au>Iveta Kanepe-Lapsa</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Novel éthynylxanthines, their preparation and use as inhibitors of matrix metalloproteinases and angiogenesis</title><date>2018-04-18</date><risdate>2018</risdate><abstract>The present invention relates to a novel ethynylxanthine derivatives of formula (I) which exhibit ability selectively suppress matrix metalloproteinases and therefore may act as inhibitors of angiogenesis, methods for their synthesis and use for the treatment and/or prevention of various diseases and disorders caused by overexpression of matrix metalloproteinases by administration of such substances</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_GB2553685A8
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Novel éthynylxanthines, their preparation and use as inhibitors of matrix metalloproteinases and angiogenesis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T14%3A39%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Valerjans%20Kauss&rft.date=2018-04-18&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EGB2553685A8%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true